Stromal Micropapillary Component as a Novel Unfavorable Prognostic Factor of Lung Adenocarcinoma

Diagnostic Pathology - United Kingdom
doi 10.1186/1746-1596-7-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genetic Alterations in Lung Adenocarcinoma With a Micropapillary Component

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Histopathological Features and Prognostic Significance of the Micropapillary Pattern in Lung Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2008English

Integrated TCGA Analysis Implicates lncRNA CTB-193M12.5 as a Prognostic Factor in Lung Adenocarcinoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2018English

P3.16-03 Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2019English

Transforming Growth Factor Beta 1 as a Prognostic Factor in Pulmonary Adenocarcinoma.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1994English

Hepatoma‑derived Growth Factor Functions as an Unfavorable Prognostic Marker of Human Gliomas

Oncology Letters
Cancer ResearchOncology
2017English

MA09.06 the Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) Is as Clinically Important as the Classical Pattern

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

ERRα Is an Aggressive Factor in Lung Adenocarcinoma Indicating Poor Prognostic Outcomes

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy